BIOCANCELL THERAPEUTICS INC.·4

Mar 8, 10:44 AM ET

Weinstein Ira 4

4 · BIOCANCELL THERAPEUTICS INC. · Filed Mar 8, 2011

Insider Transaction Report

Form 4
Period: 2011-03-06
Weinstein Ira
CFO & COO
Transactions
  • Award

    Employee Options

    2011-03-06+20,000170,000 total
    Exp: 2021-03-06Common Stock (20,000 underlying)
Footnotes (2)
  • [F1]The exercise price is 2.85 NIS per share.
  • [F2]3,750 options shall vest and be exercisable immediately, and an additional 1,250 options shall vest and be exercisable at the end of each calendar quarter, from March 31, 2011 until all are vested or until vesting is terminated in accordance with the terms of the options.

Documents

1 file
  • 4
    doc1.xmlPrimary

    FORM 4